UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Jun

    20

    UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference

    Read More Share:linkedin| twitter| email| facebook

    Jun

    17

    Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.

    Read More Share:linkedin| twitter| email| facebook

    Jun

    13

    Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis

    Read More Share:linkedin| twitter| email| facebook

    Jun

    12

    UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

    Read More Share:linkedin| twitter| email| facebook

    Jun

    11

    BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis

    Read More Share:linkedin| twitter| email| facebook

    Jun

    04

    Resources for Resilience: Dravet Syndrome Awareness Month for Families Living with DEEs

    Read More Share:linkedin| twitter| email| facebook

    Jun

    02

    Partnering with Patient Communities to Advance HS Awareness and Care

    Read More Share:linkedin| twitter| email| facebook

    May

    30

    Recognizing Myasthenia Gravis Month – The Importance of Addressing Unmet Patient Needs

    At UCB, we work 365-days-a-year to find new ways to deliver solutions, peace of mind, and opportunities to people living with severe diseases because everyone deserves to live the best life they can.

    Read More Share:linkedin| twitter| email| facebook

    Apr

    22

    Earth Day 2025: Advancing Our Commitment to a Healthier Planet

    Read More Share:linkedin| twitter| email| facebook

    Apr

    03

    UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025

    Read More Share:linkedin| twitter| email| facebook

    © 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
    USPR-CORP-0115-00003(2)

    OSZAR »